Sinil Pharmaceutical Co's quarterly market cap
increased
from Sep. 2023 (₩78,490 Mil) to Dec. 2023 (₩89,125 Mil) but then
declined
from Dec. 2023 (₩89,125 Mil) to Mar. 2024 (₩84,963 Mil).
Sinil Pharmaceutical Co's annual market cap
declined
from Dec. 2021 (₩126,468 Mil) to Dec. 2022 (₩94,552 Mil) and
declined
from Dec. 2022 (₩94,552 Mil) to Dec. 2023 (₩89,125 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sinil Pharmaceutical Co's Enterprise Value for Today is ₩57,066 Mil.
Sinil Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinil Pharmaceutical Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Sinil Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinil Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sinil Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Sinil Pharmaceutical Co's Market Cap falls into.
Sinil Pharmaceutical Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sinil Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinil Pharmaceutical Co (XKRX:012790) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sinil Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of Sinil Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinil Pharmaceutical Co (XKRX:012790) Business Description
Sinil Pharmaceutical Co Ltd is a South Korean drug manufacturing company. The products of the company include diphene gel, tour pen plasta, oriental herb tea cold liquid, and griffen ssung.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:012790 has been successfully added to your 